Angiotensin II for Distributive Shock

PHASE4RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

June 1, 2024

Study Completion Date

December 31, 2024

Conditions
Distributive Shock
Interventions
DRUG

Angiotensin II

Angiotensin II started at 5 ng/kg/min and titrated in 5-10 ng/kg/min increments every 5 minutes up to 80ng/kg/min to achieve target arterial pressure (MAP)

DRUG

Placebo

Placebo

Trial Locations (1)

60611

RECRUITING

Northwestern University, Chicago

Sponsors
All Listed Sponsors
collaborator

La Jolla Pharmaceutical Company

INDUSTRY

lead

Northwestern University

OTHER

NCT04904562 - Angiotensin II for Distributive Shock | Biotech Hunter | Biotech Hunter